3D X-Ray Beam Metrology
CyberKnife Quality Assurance
Quality Assurance FAQs
3D BGA Inspection
OCR/Barcodes
Downloads
Contact

 

XRV-100 and IBAC Frequently Asked Questions

 

Contents

1. Why is radiosurgery system Quality Assurance (QA) important?. 1

2. What happens when QA isn't done correctly?. 1

3. What makes radiosurgery system QA hard to get right?. 2

4. What advantages does the XRV-100 have over other calibration systems?. 2

4.1 XRV-100 Advantages over Film.. 2

4.2 XRV-100 Advantages over Radiation Sensors. 2

4.3 XRV-100 Advantages over Water Tank Systems. 2

5. Which QA test best highlights the capabilities of the XRV-100?. 3

6. How does the XRV-100 contribute to the measurement of the radiation dose?. 3

6.1 Total System QA.. 3

6.2 Fluence QA.. 3

7. Can the XRV-100 perform patient specific QA?. 4

8. What is the difference between the XRV-100 and the IBAC?. 4

9. Which radiosurgery systems are compatible with the XRV-100?. 4

10. Can the XRV-100 be used with proton therapy systems?. 4

 

 

 

1. Why is radiosurgery system Quality Assurance (QA) important?

Calibration is essential to confirm the accuracy of the treatment system.  The success of any treatment plan requires that the beam be delivered exactly where it is aimed, and that the actual beam energy profile matches the expected beam energy profile used by patient treatment planning software.

 

The American Association of Physicists in Medicine (AAPM) Task Group 142 recommends a daily complete end-to-end test of both imaging guidance and therapy radiation to ensure that patients are being given a maximum therapeutic dose at the tumor and that nearby organs at risk are not being damaged in the process.

 

 

2. What happens when QA isn't done correctly?

Every patient treatment is a risk.  A radiation mistake can inflict serious injury on a patient, which is the top concern of the clinic.  The effects can ripple outward to include legal expenses, damage to the institution's reputation, and loss of confidence by the customer base.

 

A series of articles in the New York Times has described some of the tragic, and even fatal, results of treatments delivered at the wrong dose or in the wrong place.  In the second reference, flawed QA is identified as responsible for 28% of radiation treatment mistakes.  Hardware and software malfunctions contribute to another 7% of the mistakes. 

 

The errors are occurring despite the use of these institutions' standard QA procedures.

 

'The Radiation Boom:  Radiation Offers New Cures, and Ways to Do Harm' by Walt Bogdanich, 1/23/10

http://www.nytimes.com/2010/01/24/health/24radiation.html?_r=1

 

'Radiation Mistakes:  One State's Tally'

http://www.nytimes.com/imagepages/2010/01/24/us/24radiation_graphic.html?ref=health

 

'The Radiation Boom:  As Technology Surges, Radiation Safeguards Lag' by Walt Bogdanich, 1/26/10

http://www.nytimes.com/2010/01/27/us/27radiation.html?fta=y

 

'The Radiation Boom:  Case Studies:  When Medical Radiation Goes Awry' by Walt Bogdanich 1/26/10

http://www.nytimes.com/2010/01/27/us/27RADIATIONSIDEBAR.html

 

'Radiation Bills Raise Questions of Supervision' by Walt Bogdanich and Rebecca R. Ruiz, 2/25/10

http://www.nytimes.com/2010/02/26/us/26radiation.html?fta=y

 

'At Hearing on Radiation, Calls for Better Oversight' by Walt Bogdanich, 2/26/10

http://www.nytimes.com/2010/02/27/health/policy/27radiation.html?fta=y

 

 

3. What makes radiosurgery system QA hard to get right?

Part of the problem is that current QA tools require a substantial amount of time to use properly.  Tools that are tedious to use are tools that may not be used frequently enough to thoroughly test all aspects of a radiosurgery system.  There is a need for QA tools that are easy to set up, easy to use, and that produce comprehensive data sets that are easy to understand.  

 

 

4. What advantages does the XRV-100 have over other calibration systems?

Existing dose measuring technologies such as film, ionization chambers/diodes, and water tanks have their own specific limitations.  The XRV-100 compensates for their limitations by providing more useful data, in a shorter time, with a lower cost-penalty-per-test.  

 

4.1 XRV-100 Advantages over Film

A piece of film can only produce 2D information, so multiple pieces of film must be used to construct the 3D information needed to diagnose the delivery robot/gantry accuracy.  Each piece of film adds to the cost of a test.  The technician's time to position, expose, and scan the film is a recurrent cost.  Film handling also introduces the potential for human error.

·         The XRV-100 sets up faster, produces 3D data more quickly, requires no human intervention, and has a lower cost-per-test.

 

4.2 XRV-100 Advantages over Radiation Sensors

Ionization chambers and diodes can only measure radiation at a single point in space.  They cannot detect local gradients in the radiation field and cannot provide 3D information about the direction of the radiation.  These devices must be placed in 2D/3D arrays to allow adequate data to be captured, which adds significantly to the test system cost and complexity. Because there are gaps between the individual devices (4 to 10 mm), the sensor's resolution may be inadequate for providing reliable 3D information for small diameter beams. 

·         The XRV-100 detects local gradients, provides 3D information about the direction of the radiation, has finer resolution with repeatability close to .05 mm for positional information, and has a lower cost-per-test.

 

4.3 XRV-100 Advantages over Water Tank Systems

In water tank systems, a single ionization chamber or diode is mechanically moved through a volume of water in order to develop 3D information about the radiation field.  The mechanisms needed to move the radiation sensor through the medium are slow.  Beam QA with this technique is typically done on a yearly basis and provides no information about the aiming accuracy of the robot/gantry.  The cost penalty for each test is high.  

·         The XRV-100 provides real-time 3D information, making it convenient to use daily or even before each treatment.  Because of the lower cost of an XRV-100 unit and the much shorter time that the treatment room must be closed to perform the tests, it has a lower cost-per-test.

 

 

5. Which QA test best highlights the capabilities of the XRV-100?

The XRV-100 performs end-to-end tests quickly and accurately.  Because the XRV-100 monitors the X-ray beam position and energy profile in real-time, the end-to-end tests can be repeated many times with different size beam widths, fully exercising all of the major subcomponents of the radiosurgery system in a single session.

 

The XRV-100 improves upon the industry standard Winston-Lutz test.  Typically, Winston-Lutz style tests assume the beam is symmetrical with no discontinuities, and infers the isocenter position using calculations based on the penumbra.  The XRV-100 directly measures the isocenter of the treatment beam, allowing it to detect asymmetrical beams or discontinuities without making assumptions.

 

In addition, as soon as the radiosurgery gantry stops moving and the beam is turned off, the XRV-100 test results are ready to view.  There is no radiochromic film that must first be extracted from the phantom, hand carried to the scanner, subjected to the scanning process, etc.  The XRV software immediately displays the full test results on a computer conveniently located adjacent to the treatment room.

 

 

6. How does the XRV-100 contribute to the measurement of the radiation dose?

A treatment plan usually consists of many different radiation beams applied at different angles, shapes, energies, and durations.  The delivered dose of radiation from a single beam is based on the location of the beam, the kind of tissue it is traveling through, the initial energy of the beam, the shape of the beam, and how long the beam is on.  Consequently, the therapeutic dose is a three-dimensional volume located within the patient or phantom, with each point in the volume having a unique amount of delivered radiation contributed by many individual beams. 

 

6.1 Total System QA

The XRV-100 verifies the performance of the radiation delivery robot/gantry, tumor tracking cameras (kV imagers), beam shaping mechanism (MLC or Iris), and X-ray source (linear accelerator), and overall control system.

 

6.2 Fluence QA

The XRV-100 determines the beam vector, position, and energy profile by measuring the X-ray photons or fluence and how accurately those photons are delivered to a target in 3D space.  These photons will produce the radiation dose by stripping the electrons off of the atoms in its path.  If the photons are not delivered in an accurate fashion, the dose will not be accurate.  

 

The XRV-100 captures and analyzes X-ray fluence, not dose. Measuring fluence is in many ways superior to measuring dose, but since dose-based measurements are the industry standard, the XRV-100 should be thought of as an adjunct to the existing technologies of film, ion chambers, diodes, etc.

 

 

7. Can the XRV-100 perform patient specific QA?

A module is in development that will deliver XRV-100 test data in a format that can be used to compare delivered beam data to the dose volume created in the patient's original treatment plan.

 

 

8. What is the difference between the XRV-100 and the IBAC?

The XRV-100 is a phantom that takes the place of the patient on the treatment couch and is used for targeting and dose/fluence delivery testing.  The XRV-100 can measure the vector location of the X-ray beam, the beam shape and intensity, and the pointing accuracy of the robot mechanism.

 

The IBAC is a collimator testing device that directly attaches to the CyberKnife Iris and can measure the real-time performance of the collimator beam shaping mechanism as well as the energy profile of the beam as it emerges from the collimator.  For simultaneous measurement of the beam direction, it can be used in conjunction with the XRV-100.

 

 

9. Which radiosurgery systems are compatible with the XRV-100?

The XRV-100 is best used on radiosurgery systems that can target a tumor using implanted fiducials or via recognition of bony features.  This is called frameless or image guided radiotherapy (IGRT).  The Accuray CyberKnife and Varian TrueBeam systems are examples of these machine types.  The XRV-100 is also useful on Varian Trilogy and TomoTherapy machines. 

 

 

10. Can the XRV-100 be used with proton therapy systems?

Because the fundamental principles are the same for the overall hardware and software, the XRV-100 is expected to be compatible with proton therapy systems.  We are actively seeking research partners in this emerging field.

 

back to top

 

Logos Systems Int'l
175 El Pueblo Rd.
Scotts Valley, CA     95066
Phone: (831) 600-6101
Fax: (831) 439-9440
Email: sales@logosvisionsystem.com